Form 4 for ALLE Allegion
Accepted 2024-11-26 00:00:00 ET · period of report 2024-11-22 · accession 0001127602-24-028098 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-11-26 | 2024-11-22+ | ALLE | Eckersley Timothy P | SVP-Allegion International | M - OptEx | $87.53 | +14.7K | 43.0K | +52% | +$1.29M |
| DM | 2024-11-26 | 2024-11-22+ | ALLE | Eckersley Timothy P | SVP-Allegion International | S - Sale+OE | $142.20 | -14.7K | 33.3K | -31% | -$2.09M |
| DM | 2024-11-26 | 2024-11-22+ | ALLE | Eckersley Timothy P | SVP-Allegion International | M - OptEx | $0.00 | -14.7K | 2,046 | -88% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2024-11-22 | M | A | 5,000 | $86.93 | 38,292.74 | D | — | — | (F1) Includes acquisition of shares through a dividend reinvestment plan. |
| 2 | Common | Ordinary Shares | 2024-11-25 | S | D | 9,707 | $142.63 | 33,292.74 | D | — | — | (F3) This transaction was executed in multiple transactions ranging from $142.36 to $142.83 per share. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provided upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. |
| 3 | Common | Ordinary Shares | 2024-11-22 | S | D | 5,000 | $141.37 | 33,292.74 | D | — | — | (F2) This transaction was executed in multiple sales ranging from $141.10 to $141.74 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 4 | Common | Ordinary Shares | 2024-11-25 | M | A | 2,046 | $86.93 | 35,338.74 | D | — | — | |
| 5 | Common | Ordinary Shares | 2024-11-25 | M | A | 7,661 | $88.08 | 42,999.74 | D | — | — | |
| 6 | Derivative | Stock Option (Right to Buy) | 2024-11-25 | M | D | 7,661 | $0.00 | 0 | D | $88.08 · — to 2029-02-21 | 7,661 Ordinary Shares | (F5) A stock option that vested in equal annual installments on February 21, 2020, February 21, 2021 and February 21, 2022, and is exercisable. |
| 7 | Derivative | Stock Option (Right to Buy) | 2024-11-25 | M | D | 2,046 | $0.00 | 0 | D | $86.93 · — to 2028-02-22 | 2,046 Ordinary Shares | (F4) A stock option that vested in equal annual installments on February 22, 2019, February 22, 2020 and February 22, 2021, and is exercisable. |
| 8 | Derivative | Stock Option (Right to Buy) | 2024-11-22 | M | D | 5,000 | $0.00 | 2,046 | D | $86.93 · — to 2028-02-22 | 5,000 Ordinary Shares | (F4) A stock option that vested in equal annual installments on February 22, 2019, February 22, 2020 and February 22, 2021, and is exercisable. |